Adam Muzikant, Chief Business Officer at Flexion Therapeutics Inc (FLXN), sold 4,005 shares at $11.13 ($45K) on 2021-01-05, disclosed to the SEC on 2021-01-07.
Open-market sale of $45k FLXN by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.